Arcturus Therapeutics
ARCT
#7825
Rank
โ‚ฌ0.38 B
Marketcap
13,60ย โ‚ฌ
Share price
-1.52%
Change (1 day)
-11.06%
Change (1 year)

EPS for Arcturus Therapeutics (ARCT)

EPS in 2026 (TTM): -2,40ย โ‚ฌ

According to Arcturus Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,45ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,08ย โ‚ฌ an increase over its 2024 EPS that were of -2,63ย โ‚ฌ.

EPS history for Arcturus Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,40ย โ‚ฌ15.8%
2025-2,08ย โ‚ฌ-20.93%
2024-2,63ย โ‚ฌ201%
2023-0,87ย โ‚ฌ-394.12%
20220,30ย โ‚ฌ-104.39%
2021-6,75ย โ‚ฌ
2019-1,81ย โ‚ฌ
2016-5,43ย โ‚ฌ-1.11%
2015-5,49ย โ‚ฌ
2013-5,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-0,05233ย โ‚ฌ-97.86% Bahamas
NRC Health
NRC
0,34ย โ‚ฌ-113.88%๐Ÿ‡บ๐Ÿ‡ธ USA